Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
Phase 3 – large-scale trial before approval
Conditions:
Generalized Myasthenia Gravis
Sponsor: UCB Biopharma SRL
trial.available_in:
БГ
Overview
The RAISE-XT study is an open-label extension study to evaluate the long-term efficacy, safety, and tolerability of zilucoplan in subjects with gMG who have previously participated in a qualifying Ra Pharmaceuticals sponsored zilucoplan study.
Who can participate
Inclusion Criteria:
* Completion of a qualifying zilucoplan study
Exclusion Criteria:
* With the exception of a prior zilucoplan trial, participation in another concurrent clinical trial involving an experimental therapeutic intervention (participation in observational studies and/or registry studies is permitted)
БГ